{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:49:32Z","timestamp":1788306572647,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/bf02758571","type":"journal-article","created":{"date-parts":[[2007,11,24]],"date-time":"2007-11-24T12:45:50Z","timestamp":1195908350000},"page":"437-438","source":"Crossref","is-referenced-by-count":5,"title":["Primitive neuroectodermal tumor (PNET) as second malignancy after treatment of Hodgkin\u2019s disease"],"prefix":"10.1007","volume":"73","author":[{"given":"A.","family":"Khadwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Kurkure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02758571_CR1","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","volume":"20","author":"AK Ng","year":"2002","unstructured":"Ng AK, Bernardo MP, Weller Eet al. Long-term survival and competing causes of death in patients with early-stage Hodgkin\u2019s disease treated at age 50 or younger.J Clin Oncol 2002; 20: 2101\u20132108.","journal-title":"J Clin Oncol"},{"key":"BF02758571_CR2","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1200\/JCO.2003.11.059","volume":"21","author":"S Bhatia","year":"2003","unstructured":"Bhatia S, Yasui Y, Robison LLet al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin\u2019s disease: Report from the Late Effects Study.J Clin Oncol 2003, 21: 4386\u20134394.","journal-title":"J Clin Oncol"},{"key":"BF02758571_CR3","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","volume":"20","author":"GM Dores","year":"2002","unstructured":"Dores GM, Metayer CM, Curtis REet al. Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: A population-based evaluation over 25 years.J Clin Oncol 2002; 20: 3484\u20133494.","journal-title":"J Clin Oncol"},{"key":"BF02758571_CR4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/bmj.304.6835.1137","volume":"304","author":"AJ Swerdlow","year":"1992","unstructured":"Swerdlow AJ, Douglas AJ, Hudson GVet al. Risk of second primary cancers after Hodgkin\u2019s disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.BMJ 1992; 304: 1137\u20131143.","journal-title":"BMJ"},{"key":"BF02758571_CR5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/jnci\/88.5.270","volume":"88","author":"MM Hawkins","year":"1996","unstructured":"Hawkins MM, Wilson LM, Burton HSet al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.J Natl Cancer Inst 1996; 88: 270\u2013278.","journal-title":"J Natl Cancer Inst"},{"key":"BF02758571_CR6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJM198709033171002","volume":"317","author":"MA Tucker","year":"1987","unstructured":"Tucker MA, D\u2019Angio GJ, Boice JD Jret al. Bone sarcomas linked to radiotherapy and chemotherapy in children.N Engl J Med 1987; 317: 588\u2013593.","journal-title":"N Engl J Med"},{"key":"BF02758571_CR7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/10428199509056865","volume":"17","author":"R Delgado-Chavez","year":"1995","unstructured":"Delgado-Chavez R, Sobrevilla-Calvo P, Green-Schneewiss Let al. Peripheral neuroectodermal tumor of the chest wall in a patient treated for Hodgkin\u2019s disease.Leuk Lymphoma 1995; 17: 509\u2013513.","journal-title":"Leuk Lymphoma"},{"key":"BF02758571_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF01695039","volume":"68","author":"AP Anselmo","year":"1994","unstructured":"Anselmo AP, Cartoni C, Pacchiarotti Aet al. Peripheral neuroectodermal tumor of the chest (Askin tumor) as secondary neoplasm after Hodgkin\u2019s disease: a case report.Ann Hematol 1994; 68: 311\u2013313.","journal-title":"Ann Hematol"},{"key":"BF02758571_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ajh.20012","volume":"76","author":"CR Suarez","year":"2004","unstructured":"Suarez CR, Bertolone SJ, Raj ABet al. Second malignant neoplasms in childhood acute lymphoblastic leukemia: primitive neuroectodermal tumor of the chest wall with germline p53 mutation as a second malignant neoplasm.Am J Hematol 2004; 76: 52\u201356.","journal-title":"Am J Hematol"},{"key":"BF02758571_CR10","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1200\/JCO.1999.17.4.1259","volume":"17","author":"KE Nichols","year":"1999","unstructured":"Nichols KE, Levitz S, Shannon KEet al. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin\u2019s disease.J Clin Oncol 1999; 17: 1259.","journal-title":"J Clin Oncol"},{"key":"BF02758571_CR11","first-page":"83","volume":"10","author":"KE Nichols","year":"2001","unstructured":"Nichols KE, Malkin D, Garber JEet al. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancer.Cancer Epidemiol Biomarkers Prev 2001; 10: 83\u201387.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF02758571_CR12","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1200\/JCO.2003.12.042","volume":"21","author":"KE Nichols","year":"2003","unstructured":"Nichols KE, Heath JA, Friedman Det al. TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin\u2019s disease with second primary neoplasms.J Clin Oncol 2003; 21: 4505\u20134509.","journal-title":"J Clin Oncol"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02758571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02758571\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02758571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T13:11:58Z","timestamp":1558357918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02758571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["BF02758571"],"URL":"https:\/\/doi.org\/10.1007\/bf02758571","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}